Advances in regenerative medicine are opening new possibilities for the treatment of chronic conditions that have traditionally relied on symptom management. As innovative therapeutic strategies continue to emerge, communicating their potential to the wider public is essential.
Fetalix was featured in Revista Sábado, one of Portugal's leading general-interest magazines, in an article exploring new approaches to the treatment of pain. The feature brought together perspectives from experts working across different areas of research and clinical practice to discuss innovative strategies aimed at improving patients' quality of life.
As part of the article, Fetalix co-founder and CEO Joana Caldeira shared insights into the potential of regenerative medicine and decellularized extracellular matrix-based biomaterials to promote tissue repair. The interview highlighted how these emerging approaches seek to address the underlying causes of tissue degeneration, with the long-term goal of reducing pain through regeneration rather than symptom relief alone.
By contributing to discussions in mainstream media, Fetalix continues to raise awareness of regenerative medicine and the scientific advances that are shaping the future of healthcare.
April 28, 2026
Image credit: Revista Sábado
